DaVita
DVA
$232.51
Share price
0.45%
Change (1 day)
3.08%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
Market capitalization of DaVita (DVA)
Market cap: NZ$18.60 Billion
As of April 2025 DaVita has a market cap of NZ$18.60 Billion. This makes DaVita the world's 1540th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of DaVita from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$18.60 B | -17.11% |
| 2024 | NZ$22.44 B | 48.3% |
| 2023 | NZ$15.13 B | 42.8% |
| 2022 | NZ$10.59 B | -37.56% |
| 2021 | NZ$16.97 B | -6.87% |
| 2020 | NZ$18.22 B | 29.98% |
| 2019 | NZ$14.01 B | 9.83% |
| 2018 | NZ$12.76 B | -31.55% |
| 2017 | NZ$18.64 B | 1.92% |
| 2016 | NZ$18.29 B | -14.36% |
| 2015 | NZ$21.36 B | 2.49% |
| 2014 | NZ$20.84 B | 26.81% |
| 2013 | NZ$16.43 B | 15.97% |
| 2012 | NZ$14.17 B | 56.07% |
| 2011 | NZ$9.08 B | 5.03% |
| 2010 | NZ$8.64 B | 3.74% |
| 2009 | NZ$8.33 B | -5.99% |
| 2008 | NZ$8.86 B | 12.5% |
| 2007 | NZ$7.88 B | -6.71% |
| 2006 | NZ$8.44 B | 11.86% |
| 2005 | NZ$7.55 B | 38.31% |
| 2004 | NZ$5.46 B | 41.1% |
| 2003 | NZ$3.86 B | 34.68% |
| 2002 | NZ$2.87 B | -42.38% |
| 2001 | NZ$4.98 B | 57.11% |
| 2000 | NZ$3.17 B | 205.45% |
| 1999 | NZ$1.03 B | -77.14% |
| 1998 | NZ$4.54 B | 115.12% |
| 1997 | NZ$2.11 B | 55.64% |
| 1996 | NZ$1.35 B |
End of Day market cap according to different sources
On Apr 23rd, 2025 the market cap of DaVita was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$19.53 B | 5.02% | 🇺🇸 USA |
 | NZ$1.78 B | -90.39% | 🇺🇸 USA |
 | NZ$18.90 B | 1.62% | 🇺🇸 USA |
 | NZ$31.86 B | 71.30% | 🇺🇸 USA |